Results 191 to 200 of about 644,115 (313)

Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord, 2023
Park DY, An S, Arif AW, Sana MK, Vij A.
europepmc   +1 more source

Sulfated, low-molecular-weight lignins are potent inhibitors of plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies [PDF]

, 2009
Brian L. Henry, May H. Abdel Aziz, Qibing Zhou, Umesh R. Desai   +3 more
openalex   +1 more source

Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study. [PDF]

J Clin Med, 2022
Rauch S, Müller HP, Dreyhaupt J, Ludolph AC, Kassubek J, Althaus K.   +5 more
europepmc   +1 more source

Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors III. Effect of Ring Opening of Piperazinone Moiety on Inhibition

, 2004
Hidemitsu Nishida, Yutaka Miyazaki, Takafumi Mukaihira, Hiroyasu Shimada, Kazuhiro Suzuki, Fumihiko Saitoh, Masashi Mizuno, Tomokazu Matsusue, Atsushi Okamoto, Yoshitaka Hosaka, Miwa Matsumoto, Shuhei Ohnishi, Hidenori Mochizuki   +12 more
openalex   +2 more sources

The Efficacy of Andexanet Alfa for the Reversal of Factor Xa Inhibitors Is Not Influenced by Hemodilution with Different Volume Expanders. [PDF]

J Clin Med
Wienhold J, Rossaint R, Vandeput E, Grottke O.   +3 more
europepmc   +1 more source

An Evaluation of Time to Therapeutic Range of Intravenous Unfractionated Heparin After Transitioning From Direct Oral Factor Xa Inhibitors. [PDF]

Hosp Pharm, 2023
Lawing L, Yook J, Ray M, Smith SE.
europepmc   +1 more source

Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation [PDF]

, 2010
Hui‐Kyung Jeon, Li‐Ming Lien, Wen-Ter Lai, Hung‐Fat Tse, Wook-Sung Chung, Tsong-Hai Lee, Shih-Ann Chen, Namsik Chung   +7 more
openalex   +1 more source

Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective Study. [PDF]

Kidney Int Rep
Arches C, Jalal-Eddine A, Titeca-Beauport D, Dao M, Lobbedez T, Zaoui P, Masset C, Bertrand D, El Karoui K, Brenier H, Sakhi H, Peiffer B, Audard V, Joher N.   +13 more
europepmc   +1 more source

Comparison of outcomes in patients with intracranial hemorrhage on factor Xa inhibitors versus vitamin K antagonists treated with 4-factor prothrombin complex concentrate

Proceedings, 2018
Sarah Harrison, J. Garrett, Kelsey N Kohman, J. Kline   +3 more
semanticscholar   +1 more source

Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department. [PDF]

Am J Health Syst Pharm, 2022
Zepeski AE, Faine BA, Merrill AE, Sutamtewagul G, Bhagavathi S.   +4 more
europepmc   +1 more source